CHYM SEC Filings
SEC filings for CHYM. Annual and quarterly reports, 8-K events, Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 10-QAIChime's MD&A reports strong year-over-year growth in revenue, Active Members and profitability, and a swing to net income after the IPO-related stock compensation charge in the prior year. | Aug 6, 2026 | 0001795586-26-000048EDGAR |
| 10-QAIChime's Q1 2026 MD&A is upbeat and factual, highlighting 25% revenue growth, a swing to $53.5 million net income, adjusted EBITDA margin expansion from 5% to 18%, and lower transaction losses. | May 7, 2026 | 0001795586-26-000038EDGAR |
| 10-Q | Nov 10, 2025 | 0001795586-25-000019EDGAR |
SEC filings for companies related to CHYM
Never miss a CHYM filing.
Get an email when CHYM files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.